David Scadden - Jun 3, 2021 Form 4 Insider Report for Editas Medicine, Inc. (EDIT)

Role
Director
Signature
/s/ David Scadden
Stock symbol
EDIT
Transactions as of
Jun 3, 2021
Transactions value $
$0
Form type
4
Date filed
6/7/2021, 04:14 PM
Previous filing
Jun 3, 2021
Next filing
May 24, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EDIT Stock Option (right to buy) Award $0 +11.5K $0.00 11.5K Jun 3, 2021 Common Stock 11.5K $33.36 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on June 3, 2021 and is scheduled to vest in full on June 3, 2022.